NYSE$CRL

Charles River Laboratories International Inc · Q1 2022 earnings

Q1 2022 earnings · · Investor relations

Briefing

Charles River Labs reported first-quarter results with revenue of $913.9 million and GAAP earnings per share of $1.81.

Charles River Laboratories International, Inc. reported first-quarter revenue of $913.9 million, a 10.8% increase from the first quarter of 2021. GAAP earnings per share were $1.81, and non-GAAP earnings per share were $2.75. The company updated its 2022 financial guidance, increasing reported revenue growth guidance by 50 basis points.

  • First-quarter revenue was $913.9 million, up 10.8% year-over-year.
  • First-quarter GAAP earnings per share were $1.81, a 50.8% increase year-over-year.
  • First-quarter non-GAAP earnings per share were $2.75, an 8.7% increase year-over-year.
  • The company updated its 2022 financial guidance, increasing reported revenue growth guidance.

Headline financials

Total Revenue

$914M

Previous: $825M+10.8%
EPS (adj)

$2.75

Previous: $2.53+8.7%
Free Cash Flow

$93M

Previous: $61.5M+51.2%
Net Income

$93M

Previous: $61.5M+51.2%
Operating Income

$149M

Previous: $124M+20.3%
Gross Profit

$7.9M

Previous: $374K+2012.3%
Cash & Equivalents

$242M

Previous: $465M-48.0%
Total Assets

$7.08B

Previous: $5.81B+21.8%
Stock-Based Comp

$14.6M

Previous: $13.2M+10.8%

Revenue & EPS history

Charles River Labs · Revenue · Quarterly

$914M

Q1 2022+10.8%vs Q1 2021
Beat estimate in 15 of 16 quarters(94%)
ActualEstimate

Revenue by segment

Charles River Labs · $914M total across 3 segments · Q1 2022

  • Discovery & Safety Assessment
    $544M+8.6%
  • Manufacturing Solutions
    $193M+31.8%
  • Research Models & Services
    $177M-0.2%

Forward guidance

The Company is updating its 2022 financial guidance, which was previously provided on February 16, 2022. Reported revenue growth guidance is being increased by 50 basis points to 13.5% to 15.5% to reflect the Explora BioLabs acquisition, which was completed on April 5, 2022, partially offset by unfavorable movements in foreign currency translation. Organic revenue growth guidance remains unchanged for 2022.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2022

Historical avgQ1 2022

+0.1%

Avg return

Earnings day

+0.5%

Avg return

5 days after

+0.7%

Avg return

30 days after

47%

32 / 68 earnings

Positive

+18.4%

Q1 2025

Best reaction

-13.3%

Q3 2017

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+1.8%-9.0%-0.1%
Q4 2025-1.8%+3.1%-3.1%
Q3 2025-5.5%-5.0%+3.6%
Q1 2025+18.4%+24.0%+25.4%
Q4 2024+6.9%+10.4%+8.3%
Q3 2024+11.5%+17.0%+1.7%
Q2 2024-11.7%-15.1%-17.8%
Q1 2024-3.0%-1.0%-8.7%
Q4 2023+11.4%+11.2%+17.6%
Q3 2023-7.3%-7.0%+11.8%
Q2 2023+5.5%+5.2%-3.2%
Q1 2023+2.7%+1.0%+6.1%
Q4 2022-6.7%-9.0%-20.4%
Q3 2022+4.8%+9.0%+7.4%
Q2 2022-6.6%-9.4%-17.8%
Q1 2022-1.2%-8.9%-3.3%
Q4 2021-6.7%-6.1%-8.3%
Q3 2021-12.2%-13.4%-17.3%
Q2 2021-0.3%-0.4%+9.3%
Q1 2021+4.0%+3.2%-0.1%
Q4 2020+2.0%-1.1%-0.0%
Q3 2020+2.6%+7.0%+3.7%
Q2 2020+6.8%+7.3%+0.4%
Q1 2020+11.1%+12.0%+24.2%
Q4 2019+8.6%+11.9%-21.3%
Q3 2019-2.5%+1.1%+12.0%
Q2 2019-5.1%-10.3%-7.0%
Q1 2019-4.2%-4.1%-10.4%
Q4 2018+8.1%+9.0%+11.1%
Q3 2018+8.8%+6.8%+3.0%
Q2 2018-5.2%-6.6%-1.6%
Q1 2018+0.3%-1.0%+8.5%
Q4 2017+8.2%+6.0%+9.9%
Q3 2017-13.3%-14.3%-11.9%
Q2 2017-1.7%-0.2%+10.0%
Q1 2017-3.8%-2.3%+2.8%
Q4 2016+7.6%+7.3%+8.4%
Q3 2016-9.0%-5.1%-3.0%
Q2 2016-0.0%-3.1%-3.0%
Q1 2016+2.5%
Q4 2015+3.9%
Q3 2015+5.7%
Q2 2015+1.4%
Q1 2015-8.8%
Q4 2014+6.3%
Q3 2014-1.9%
Q2 2014+6.0%
Q1 2014-6.6%
Q4 2013-1.6%
Q3 2013-1.2%
Q2 2013+3.4%
Q1 2013-3.9%
Q4 2012+0.9%
Q3 2012-5.3%
Q2 2012+2.3%
Q1 2012+1.8%
Q4 2010-1.3%
Q4 2011-1.3%
Q3 2011-5.0%
Q2 2011-9.4%
Q1 2010-2.4%
Q1 2011-0.1%
Q4 2008-0.9%
Q3 2010-4.4%
Q3 2009-4.4%
Q2 2010+3.6%
Q4 2009+3.6%
Q2 2009+3.6%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro